Expression of CD134 (0X-40) On T Cells During the First 100 Days Following Allogeneic Bone Marrow Transplantation as a Marker for Lymphocyte Activation and Therapy-Resistant Graft-Versus-Host Disease

Author(s)

L. S. Lamb, Jr.
S. A. Abhyankar
Linda J. Hazlett, University of South Carolina - ColumbiaFollow
W. O'Neal
R. S. Folk
S. Vogt
Rudolph S. Parrish
Kerry D. Bridges
P. Jean Henslee-Downey
Adrian P. Gee

Document Type

Article

Subject Area(s)

Epidemiology and Biostatistics

Publication Info

Published in Cytometry Part A, Volume 38, Issue 5, 1999, pages 238-243.

Lamb, Jr., L. S., Abhyankar, S. A., Hazlett, L., O'Neal, W., Folk, R. S., Vogt, S., Parrish, R. S., Bridges, K., Henslee-Downey, P. J., Gee, A. P. (1999). Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease. Cytometry Part A, 38(5), 238-243.

DOI: 10.1002/(SICI)1097-0320(19991015)38:53.0.CO;2-O

© Cytometry Part A, 1999, Wiley-Blackwell

Rights

Lamb, Jr., L. S., Abhyankar, S. A., Hazlett, L., O'Neal, W., Folk, R. S., Vogt, S., Parrish, R. S., Bridges, K., Henslee-Downey, P. J., Gee, A. P. (1999). Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease. Cytometry Part A, 38(5), 238-243.

DOI: 10.1002/(SICI)1097-0320(19991015)38:53.0.CO;2-O

© Cytometry Part A, 1999, Wiley-Blackwell